Cargando…
The Pathway for New Cancer Drug Access in Canada
Cancer treatment has evolved significantly over the past decade with the emergence of a multitude of new treatments across cancer types. Alongside the pace of drug discovery, the cost of cancer drugs has also increased. In the face of this growth in development and spending, it is crucial to have an...
Autores principales: | Gotfrit, Joanna, Dempster, William, Chambers, Johanne, Wheatley-Price, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870298/ https://www.ncbi.nlm.nih.gov/pubmed/35200541 http://dx.doi.org/10.3390/curroncol29020041 |
Ejemplares similares
-
Determinants of the Cancer Drug Funding Process in Canada
por: Gotfrit, Joanna, et al.
Publicado: (2022) -
Access to Cancer Drugs in Canada
por: Wheatley-Price, Paul
Publicado: (2022) -
Cancer therapy disparity: unequal access to breast cancer therapeutics and drug funding in Canada
por: Verma, S., et al.
Publicado: (2007) -
Is Accessing Dental Care Becoming More Difficult? Evidence from Canada's Middle-Income Population
por: Ramraj, Chantel, et al.
Publicado: (2013) -
Should Canada adopt managed access agreements in Canada for expensive drugs?
por: McPhail, Melanie, et al.
Publicado: (2023)